NET PROFIT (x1000 SEK)
EMPLOYEES
Eurofins Genomics Denmark A/S
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-22,365
|
-39,591
|
-24,653 |
| Total assets |
269,964
|
200,246
|
115,292 |
| Current assets |
188,737
|
130,754
|
66,357 |
| Current liabilities |
116,126
|
84,675
|
30,688 |
| Equity capital |
-6,381
|
26,495
|
23,848 |
| - share capital |
847
|
819
|
823 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-2.4%
|
13.2%
|
20.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
162.5%
|
154.4%
|
216.2% |
| Return on equity (ROE) |
350.5%
|
-149.4%
|
-103.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.